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Abstract 
 Cancer in general in Albania is an increasing problem and cervical cancer is the 
third most common gynecologic cancer among all women. Refer to European Code Against 
cancer an important action for women to help to prevent cervical cancer is to take part in 
organised cancer screening programmes. The study aims to identify in women health beliefs 
about cervical cancer. This is a transversal and analytical study with a sample of 210 healthy 
women from Vlora city with different socio-economic and educational levels. A self-
administered questionnaire that assesses the health beliefs components about cervical cancer 
was the data collection instrument. The results highlighted low risk perception relative to 
cervical cancer. Most of women believe that cervical cancer as dangerous as all the other 
cancers and uncertainties about the chances to recover from it exist among them. 
Misunderstandings and high sensitivity relate to cervical screening. Relationship between 
perceived benefits, emotional, economic barriers and Pap test uptake was found. Large 
numbers of women never screened. The results indicated that to improve the women's 
attitudes to health, to encourage adherence to cervical screening and to avoid misconceptions 
due to lack of information conversations with health operators and the designing of effective 
prevention strategies based on health beliefs are fundamental. 
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Introduction 
 The cancer in general in Albania is an increasing problem. In the absence of the 
National Cervical Screening Program, cervical cancer is diagnosed in the last stage, therefore 
incurable with high prevalence in deaths, despite the fact it may be detected early (NCCP 
2011, p. 30). Cervical cancer is caused by sexually transmited infection with certain types of 
Human Papilloma Virus [HPV] (WHO, 2013). Infection with HPV is common, and in most 
people the body can clear the infection by itself, but sometimes the infection does not go 
away and becomes chronic, especially when it is caused by certain high-risk HPV types, can 
eventually cause cervical cancer. It can affect women of all ages, but is more common in the 
age group 30-35 years (Sastre-Garau X et al., 1996). Also, according to the American Cancer 
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Society (ACS, 2013) cervical cancer tends to occur in midlife and the risk of dying from 
cervical cancer increases as women age. The Papanicolau (Pap) smear (test) is the single 
most successful cancer screening tool in modern medicine. Based on evidence, screening via 
regular Pap test, which consists of specimen collection and interpretation of the cellular 
material decreases the incidence and mortality of cervical cancer (Justin Lappen & Dana R. 
Gossett 2012; Sengul D et al., 2014). Many low-income women do not have ready access to 
adequate health care services, including Pap smear. This means they may not get screened or 
treated for cervical pre-cancers (ACS, 2013). Reference to (WHO, 2013; NCI, 2014) regular 
screening of women between the ages of 21 and 65 years with the Pap test decreases their 
chance of dying from cervical cancer. If screening includes the Pap test and the HPV test, it 
should be repeated every 5 years. Refer to European Code Against cancer taking part in 
organised cervical cancer screening programmes help women to prevent cervical cancer 
(WHO, 2014). In conditions where the current cervical cancer screening programs and 
practices in Albania are, however casual or nonexistent (Poljak et al., 2013), the study based 
on the conceptual framework Health Belief Model (HBM) the most commonly used theory in 
health education, promotion and screening (National Cancer Institute [NCI], 2005) will 
assess women health beliefs about cervical cancer. From “Theory at a Glance: A Guide For 
Health Promotion Practice (Second Edition, 2005) in a base of HBM there are four concepts: 
perceived susceptibility, perceived severity, perceived benefits, perceived barriers. HBM 
suggests that behavior is also influenced by cues to action and self-efficacy. Perceived 
susceptibility or personal risk is the beliefs that a person has about the chances of getting a 
condition with potential change strategies to help the individual develop an accurate 
perception of his or her own risk. Perceived severity represented the beliefs about the 
seriousness of a condition and its consequences and recommended action. Perceived benefits 
are the beliefs about the effectiveness of taking action to reduce risk or seriousness and 
explain how, where and when to take action and what the potential positive results will be. 
Perceived barriers represent beliefs about the material and psychological costs of taking 
action with potential change strategies like reassurance, incentives, assistance and correct 
misinformation. Cues to action represent factors that activate ”readiness to change” and 
provide ”how to” information, promote awareness. Self-efficacy represent the confidence in 
one’s ability to take action. Different studies found this model very valid and reliable tool in 
assessing and understanding the women's health beliefs, respect of cervical cancer and Pap 
test (Walsh JC, 2006; Tacken MA et al., 2007; Guvenc G et al., 2011). 
 
Materials and methods 
Purpose  
 The purpose of this study is to identify health beliefs about cervical cancer in 
normal women. To assess the prevalence of screening among them and if there are 
differences in health beliefs between women screened and not screened. 
  
Method and samples 
 This transversal and analytical study was conducted with women who worked to 
several institutions and private enterprises in Vlora city between May and July in 2014. The 
sample study consisted of 210 normal women, with different socioeconomic and educational 
background. 
 The inclusion criteria were: Women in the target age group (25-65 years) old 
without history of hysterectomy.  
 The exclusion criteria were: Women outside the target age group (25-65) years old. 
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Data collection instrument 
 Data were obtained using a structured, self-administered questionnaire adopted in 
base of theoretical, conceptual framework Health Belief Model reference to survey 
instrument, the Cervical CAM of Cancer Research UK (2011). The questionnaire was divided 
into sections regarding beliefs of cervical cancer and Pap test. Also, included were general 
demographic characteristics and questions regarding Pap test utilization by women, in mode 
to assess the prevalence of screening. Ethical approval and support was granted by the 
respective Directors where the study was carried out. The study was also approved by the 
relevant ethics committee, and written informed consent was obtained from each participant. 
The questionnaire was completed by 234 women, but 24 of them did not meet the inclusion 
criteria of the study so were not included in the statistical analysis. 
  
Data analysis 
 All the data were entered and analysed using Epi InfoTM 7 software version 7.1.3.10 
for Windows (CDC-Epi InfoTM). Descriptive statistics and Chi-square tests were used to 
analyse the data. Single table analysis were used to assess the association between 
components of Health Belief Model for cervical cancer and women who had a Pap test. P 
values ≤ 0,05 were accepted as statistically significant. 
 
Results 
 Participant characteristics 
The sample consisted of 210 women, aged between 25 – 65 years old. Mean = 38.04, 
SD±9.34, whereas 150 (73.17%) of them were employed full time. 
 
 
 
 
 
 
 
 
 
*p-value of all variables >0.05. 
 Pap test uptake 
 
 Health beliefs components  
 
 
 
 
Table 1.  Level of education* 
Variables n  (%) 
8-year school 39 18.57 
High school 62 29.52 
Professional school 13 6.19 
University degree 79 37.62 
Master degree 15 7.14 
PhD degree 2 0.95 
Table 2.  Marital status* 
Variables n  (%) 
Married 171 81.43 
Single 25 11.90 
Divorced 12 5.71 
Widowed 2 0.95 
Table 3. Pap test prevalence 
Variables Yes No 
Have you ever had a Pap test 
N(%) N(%) 
87(41.43%) 123(58.57%) 
If yes, how many time in the 5 past years 
Variables N % 
1time 58 63.74 
2 times 20 21.98 
3times 11 12.09 
More than 3times 2 2.20 
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Perceived sensitivety 
 
Perceived risk 
*p-value of all variables >0.05, exclude less dangerous than others, p=0. 05. 
 
Perceived benefits 
 
 
 
 
 
 
 
 
Table 4.  Perceived sensitivety and Pap test uptake 
 
 
Variables 
How do you judge your risk to get cervical cancer 
 
P- value 
I have a big risk I have a low risk I don’t know 
N (%) N (%) N (%) 
H
av
e 
y
o
u
 e
v
er
 
h
ad
 a
 P
ap
 t
es
t 
Yes 
No 
15(17.86%) 
13(10.74%) 
27(32.14%) 
42(34.71%) 
42(50.0%) 
66(54.55%) 
0.345 
 
Do you believe that you have cancer lesions 
 
P- value 
Yes No I don’t know 
N (%) N (%) N (%) 
Yes 
No 
13(14.94%) 
17(13.82%) 
27(32.14%) 
53(43.09%) 
35(40.23%) 
53(43.09%) 
0.914 
Table 5.  Perceived risk and Pap test uptake 
 
 
Variables 
How dangerous is cervical cancer compared with others 
 
 
P- value 
More dangerous 
than others 
Equal to others Less than others* I don’t know 
N (%) N (%) N (%) N (%) 
H
av
e 
y
o
u
 e
v
er
 
h
ad
 a
 P
ap
 t
es
t 
Yes 
No 
18(45.%) 
22(55.0%) 
50(44.64%) 
62(55.36%) 
7(23.33%) 
23(76.67%) 
12(42.86%) 
16(57.14%) 
0.1903 
 
Chances to heal from cervical cancer 
 
P- value 
Good chances Not so good I don’t know 
N (%) N (%) N (%) 
Yes 
No 
32(41.56%) 
45(58.44%) 
41(46.59%) 
47(53.41%) 
14(31.82%) 
30(68.18%) 
0.267 
Table 6.  Perceived  benefits and Pap test uptake 
 
 
Variables 
Do you feel satisfied after the Pap test exam 
 
P- value Yes No I don’t know 
N (%) N (%) N (%) 
H
av
e 
y
o
u
 e
v
er
  
h
ad
 a
 P
ap
 t
es
t 
Yes 
No 
68(78.16%) 
59(48.36%) 
2 (2.3%) 
5(4.1%) 
17(19.54%) 
58(47.54%) 
0. 0001 
 
Is useful the regular Pap test examination 
 
P- value 
Yes No I don’t know 
N (%) N (%) N (%) 
Yes 
No 
84(96.55%) 
86(70.49%) 
1(1.15%) 
7(5.74%) 
2(2.3%) 
29(23.77%) 
0.000 
 
Pap test can detect cancer lesions before symptoms 
 
P- value 
Yes No I don’t know 
N (%) N (%) N (%) 
Yes 
No 
52(59.77%) 
40(32.79%) 
4(4.60%) 
12(9.84%) 
31(35.63%) 
70(57.38%) 
0.0005 
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Emotional barriers 
 
Economic barriers 
 
Feelings of anxiety 
Table 7.  Emotional barriers and Pap test uptake 
 
 
Variables 
The Pap test exam is painful 
 
P- value 
Yes No I don’t know 
N (%) N (%) N (%) 
H
av
e 
y
o
u
 e
v
er
 
h
ad
 a
 P
ap
 t
es
t 
Yes 
No 
23(26.44%) 
23(26.44%) 
57(65.52%) 
26(21.31%) 
7(8.05%) 
73(59.84%) 
0. 000001 
 
Doing a gynecologic exam is discomfortable 
 
P- value 
Yes No I don’t know 
N (%) N (%) N (%) 
Yes 
No 
24(27.59%) 
41(31.31%) 
63(72.41%) 
73(59.35%) 
0(0.0%) 
9(7.32%) 
0.015 
Table 8.  Economic barriers  and Pap test uptake 
 
 
Variables 
Pap test is necessary if you don’t have problems 
 
P- value 
Yes No 
N (%) N (%) 
H
av
e 
y
o
u
 e
v
er
  
h
ad
 a
 P
ap
 t
es
t 
Yes 
No 
76(44.44%) 
11(28.21%) 
95(55.56%) 
28(71.79%) 
0. 063 
 
Is expensive the Pap test examination 
 
P- value 
Yes No 
N (%) N (%) 
Yes 
No 
45(35.16%) 
42(51.22%) 
83(64.84%) 
40(48.78%) 
0.022 
 
Economic  impossibility affects  the regular screening 
 
P- value 
Yes No 
N (%) N (%) 
Yes 
No 
56(37.09%) 
31(52.54%) 
95(62.91%) 
28(47.46%) 
0.045 
 
 
Limited access of Pap service affects the regular screening 
 Yes No 
N (%) N (%) 
Yes 
No 
63(41.18%) 
24(42.11%) 
90(58.82%) 
33(57.89%) 
1.00 
Table 9.  Feelings of anxiety after Pap test and Pap test uptake 
 
 
Variables 
Fear of the results 
 
P- value 
Yes No 
N (%) N (%) 
H
av
e 
y
o
u
 e
v
er
  
h
ad
 a
 P
ap
 t
es
t 
Yes 
No 
44(34.38%) 
43(53.09%) 
84 (65.63%) 
38(46.91%) 
0. 009 
 
Can you speak freely  about cancer 
 
P- value 
Yes No 
N (%) N (%) 
Yes 
No 
51(40.16%) 
36(43.90%) 
76(59.84%) 
46(56.10%) 
0.666 
 
I will be very scared if I reveal to have cancer 
 
P- value 
Yes No 
N (%) N (%) 
Yes 
No 
72(40.68%) 
15(46.88%) 
105(59.32%) 
17(53.13%) 
0.320 
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Cues to action 
 
Discussion 
 The general characteristics of the participants shows that the average age of women 
was 38.04 years, and 73.17% of them were employed full time. 
 37.62% of women in the study (table 2) had university degree, followed by high 
school diploma, with 29.52%.         
 Table 2, shows that 81.43 % of women were married and 11.90% were single. 
Level of education (Table 1), employment and marital status shows no a statistically 
significant (p>0.05) association between women screened and not screened. This is in 
contrast with other studies were women with a lower educational level reported being 
screened less than those with higher level (Kristensson JH et al., 2014). Also, in other studies 
the most significant predictors of Papanicolaou test use were marital status (being married), 
the lack of barriers, a family history of the cancer, older age, and increased perception of 
seriousness (Boonpongmanee C et al., 2007; Berardi R et al., 2013). 
        Cervical cancer is a preventable disease, and a key aspect of its prevention is the 
detection of the premalignant lesion by cervical screening. (Morris M et al., 1996). But, in 
our study, as shows the Table 3, 58.57% of women reported that they never had a Pap test in 
their lives. Reason indicated was the lack of gynecological problems, so they did not need 
Pap test screening. However, 63.74% of the women screened reported that in the five past 
years had a Pap test only once. 
        Table 4 shows perceived sensitivety and its association with Pap test uptake. No 
statistically significance (p>0.05) association between women screened and not screened for 
this component of HBM was found. The largest percentage of women screened and not 
screened report that don`t know the risk that they have to get cervical cancer. However, in 
same means women screened and not screened reported to have low risk to get cervical 
cancer. The same situation presented for the belief that women have if they have cancer 
lesions. Factors perceived as lack of sensitivity and negligence about cervical cancer were 
found in previous studies (Ersin F, et al., 2013) 
        Table 5 shows perceived risk and its association with Pap test uptake. No statistically 
significant (p>0.05) association between women screened and not screened was found for 
this component. The two groups of women presented with same means regarding the danger 
of cervical cancer and the chances to heal from it. The only difference in means reported for 
Table 10.  Cues to action and Pap test uptake 
 
 
 
 
Variables 
Promotional campaigns on television and radio 
 
P- value 
Yes No 
N (%) N (%) 
H
av
e 
y
o
u
 e
v
er
  
h
ad
 a
 P
ap
 t
es
t 
Yes 
No 
28(32.18%) 
54 (43.90%) 
59 (67.82%) 
69(56.10%) 
0.11 
 
Conversations with health operators 
 
P- value 
Yes No 
N (%) N (%) 
Yes 
No 
82(94.25%) 
91(73.98%) 
5(5.75%) 
32(26.02%) 
0.00009 
 
Conversations in community 
 
P- value 
Yes No 
N (%) N (%) 
Yes 
No 
23(26.44%) 
27(21.95%) 
64(73.56%) 
96(78.05%) 
0.51 
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the variable less than others where women not screened had the highest percentage (76.67%). 
Also, this group reported the highest percentage (68.18%) that they don`t know what are the 
chances to heal from cervical cancer. That demonstrates that perceived sensitivity and 
perceived risk to cervical cancer and health motivation is quite low. Even if HBM suggests 
that personal risk is associated with potential change strategies to help the individual develop 
and accurate perception of his or her own risk. A study conducted by Lee et al (2002) 
identified that a large proportion of women who do not have regular smears, have a low 
perceived susceptibility. Also, a study conducted among low-income women found 
misperception of them about their perceived risk of cervical cancer (Asiedu GB et al., 2014) 
        Table 6 shows perceived benefits and its association with Pap test uptake. This results 
were statistically significant (p=0.0001) for the variable if they feel satisfied after the Pap test 
exam. As shows Table 6, 78.16% of women screened report high level of sadisfaction. There 
was also an association between women screened and if Pap test can detect cancer lesions 
before symptoms (p=0.0005).  
        Table 7 shows emotional barriers and its association with Pap test uptake. It was 
found a correlation between the two groups of women and the knowledge if Pap test exam is 
painful (p= 0.000001). Also, 65.52% of women screened report that Pap test exam is not 
painful. 31.31% of women not screened report that doing a gynecologic exam is 
discomfortable.The relationships between patterns of multiple health behaviors and use of 
recommended cancer-screening tests was demonstrated (Meissner HI et al., 2009) 
        Table 8 shows economic barriers and its association with Pap test uptake. For this 
component of HBM were included four variables. There's not a statistically significant 
difference between the two groups of women regarding the question; if Pap test is necessary 
in absence of problems; even though 44.44% of women screened and 28.21% of women not 
screened reponded yes. Statistically significant p value =0.022 cited about the cost of Pap test 
exam. 51.22% of women not screened report that Pap test is expensive. Also it was found a 
correlation between the two groups of women and if the economic impossibility affects the 
regular screening (p= 0.045). Almost half of women not screened agree the fact that the 
regular examination depends on it. The results of our study are similar with other studies 
were economic inequalities in the use of cancer screening are higher in countries without 
population-based cancer screening programmes. (Palència L et al., 2010). Also a study found 
that patients with some form of health insurance were more likely to have had a health 
maintenance visit for breast, cervical, and/or colorectal cancer screening (Carney PA et al., 
2012). 
        Table 9 shows feelings of anxiety and its association with Pap test uptake. Statistically 
significant p value = 0.009 was found for the fear of Pap test results. 53.09 % of women not 
screened report to have fear for the results. Even if for the other variables about anxiety was 
not found a statistically significant difference between the two groups of women, most of 
women who had had a Pap test and those who had never had one, report that could not speak 
freely about cancer and cancer scared them especially if the test reveals positive results. Fear, 
inadequacy of health insurance and financial problems were frequently addressed in previous 
studies.(Ersin F et al.,2013). 
        Table 10 shows cues to action and its association with Pap test uptake. For this 
component of HBM, 43.90% of women not screened report that promotional campaigns on 
television and radio are effective ways to increase the knowledge and participation in 
screening. 
 Conversations with health operators were statistically significant (p=0.00009), where 
93.25% of women screened and 73.98% of women not screened found them very effective. 
Also, conversations in community were cited by the women of the two groups with not 
statistically significant difference. A study conducted by Gillam SJ (1991) which analyzed 
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the contribution of the health belief model in cervical screening identified numerous ways of 
encouraging uptake. Those cited by women`s in the study were, also included. 
 
Conclusion 
 This study identified a series of women`s health beliefs about cervical cancer and it 
screening. Most of the perceived barriers identified were statistically significant. These 
perceived barriers (as cited in the study were previously studied using the Health Belief 
Model) influenced attendance rates at cervical cancer screenings globally. 
 The results of the study suggests that we can increase attendance on screening, 
informing women of their susceptibility to cervical cancer, and encouraging a belief that 
active participation can minimize the likelihood of developing invasive cervical cancer. 
 All this it could be possible enhancing the communication. That, also was 
highlighted by the women participating in the study. Comunication about disease, in this case 
about cervical cancer and screening is not a one way process so we as health personnel need 
to understand the women`s perceptions and concers and respond to them. Addressing 
perceived barriers will help eliminated negative attitudes towards attending cervical 
screening. 
 So, to improve the women's attitudes to health, to encourage adherence to cervical 
screening and to avoid misconceptions due to lack of information conversations with health 
operators and the designing of effective prevention strategies based on health beliefs are 
fundamental. 
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